| coronary heart disease |
phenotype |
11 |
— |
CHD |
| correct response |
phenotype |
4 |
2 |
|
| Correct trials |
phenotype |
2 |
2 |
correct memory performance |
| Cortical activity |
phenotype |
2 |
— |
|
| cortical function |
phenotype |
3 |
2 |
|
| cortical inhibition |
phenotype |
2 |
2 |
Cortical inhibition |
| cortical malformations |
phenotype |
2 |
1 |
|
| Cortical shrinkage |
phenotype |
2 |
2 |
|
| cortical thickness |
phenotype |
17 |
10 |
CT, cortex thickness, cortical thickness, regional cortical thickness, thinner cortices |
| corticosterone |
drug |
9 |
6 |
circulating corticosterone, corticosterone, corticosterone hormone, corticosterone levels |
| corticotropin-releasing factor |
drug |
7 |
5 |
CRF |
| cortisol |
drug |
18 |
11 |
cortisol levels, glucocorticoid hormone, glucocorticoid hormone cortisol, steroid hormone cortisol, stress-induced cortisol release |
| cortisol response |
phenotype |
7 |
7 |
cortisol, cortisol response, plasma cortisol |
| cotinine |
drug |
20 |
15 |
circulating cotinine level, cotinine, cotinine levels, nicotine metabolite, plasma cotinine, serum cotinine, urinary cotinine |
| cotinine levels |
drug |
2 |
1 |
cotinine |
| coumarin |
drug |
2 |
— |
|
| countries |
cohort |
2 |
2 |
countries, nation-states |
| COVID-19 pandemic |
cohort |
3 |
3 |
COVID-19, Covid pandemic, Covid-19, Covid-19 pandemic, pandemic |
| Cox6a1 |
gene |
2 |
2 |
Cytochrome c oxidase subunit 6A1 |
| CPD |
phenotype |
6 |
7 |
average CPD, cigarettes per day, cigarettes smoked per day, number of cigarettes smoked per day, quantitative smoking trait |
